Hong Kong Suspends Pfizer/BioNTech COVID-19 Shots On Loose Caps, Minor Dirt: Report

Hong Kong and Macau have temporarily suspended COVID-19 vaccines manufactured by Pfizer Inc PFE/BioNTech SE BNTX due to packaging defects in a batch of vials.

  • Vials with lot number 210102 were found to have defective packaging, authorities said.
  • Some instances where caps had been pushed out after saline was injected to dilute the vaccine, causing spillage.
  • "For the sake of precaution, the current vaccination must be suspended during the period of investigation," Hong Kong's government said in a statement.
  • Also, the government says that there is no reason to believe product safety is at risk.
  • The matter is being investigated by distributor Fosun Pharma, BioNTech, and Pfizer.
  • The city still aims to maintain the schedule for administering shot boosters, set to start from Saturday after the first doses were administered on March 10.
  • Price Action: PFE shares are trading 0.4% higher at $35.50 in the premarket session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechGovernmentNewsHealth CareGeneralCOVID-19 VaccineHong KongMaccau
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!